Healthcare & Insurance
Depression Treatments and Emerging Therapies
Depression is an often debilitating condition that causes symptoms that can disrupt the enjoyment and productivity of daily life. Symptoms range from mild to severe. It may happen in spurts throughout life, or once in a lifetime. Everyone is different when it comes to how depression is experienced.
Treatment for depression depends on several factors relating to how an individual’s symptoms manifest and their individual circumstances. The standard treatments involve psychotherapy and medications, but newer treatments are also being studied.
Clinical trials are underway to develop treatments for people who haven't responded to existing treatments. This research includes other brain stimulation treatments, psychedelic-assisted therapy, and medication with the potential for quicker relief of symptoms.
Why Depression Treatment Requires an Individual Approach
So many factors have an influence on depression. Genetics and biological function are just one aspect. Psychological and environmental factors can also play a role. It can be triggered by certain traumatic events, come on suddenly or develop insidiously over time. What this all means is that treatment requires and individual approach, not a one-size-fits-all answer.
Which treatment a person receives from their doctor depends upon many different factors, according to the National Institute of Mental Health. Some people respond positively just with psychotherapy. Others do better with a combo of meds and therapy. Still others do well solely on medication.
Traditional Depression Treatment Options
Psychotherapy has been proven over time to be an effective treatment for depression for many. This comes in many forms.
Cognitive behavioral therapy (CBT) helps patients better understand negative thought patterns and then to develop healthier responses when they encounter challenging situations.
Interpersonal psychotherapy focuses on helping patients to deal with relationship issues that may be causing depression.
Behavioral activation and psychodynamic therapy are other examples. Patients receive as many or few sessions as they need. Some patients attend weekly sessions for a few months. Others may need more extended periods of professional support.
Antidepressant medications are another very common treatment for depression. Antidepressants work by changing the activity of mood neurotransmitters. These medications are being constantly re-evaluated and improved upon. Common ones are SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake inhibitors), and tricyclic antidepressants.
Antidepressants usually take from two to several weeks before they kick in. Your doctor will check on your progress and may change your dosage as needed.
A combination of treatments is usually recommended for moderate to severe depression. Psychotherapy can help people work through behavioral and emotional issues. Medications can ease symptoms that affect daily life.
Understanding Treatment-Resistant Depression
There are times when a person doesn’t respond to treatment for their depression. This can make a person feel hopeless, which is even worse for a person already suffering from a lack of positive outlook in life.
It’s important to realize that treatment-resistant depression is being studied at length. It’s not being ignored, and there are already treatments available that cater specifically to people with treatment-resistant depression.
Doctors may suggest switching drugs, changing dose levels, or using antidepressants with other drugs. Esketamine is one that’s approved for use in persons who haven't responded to other depression treatments. But it can only be taken at a doctor's office or clinic due to its side effects and safety profile.
Clinical trials continue to study treatment-resistant depression. They look at how antidepressants work and how to determine which patients will respond to which treatments.
Brain Stimulation and Neuromodulation
Brain stimulation therapies are another option for those with severe or treatment-resistant depression. These procedures directly stimulate parts of the brain with electricity or magnetic waves.
Electroconvulsive therapy (ECT) is a common procedure that is done under general anesthesia. Controlled electric currents allow for a brief seizure to occur. ECT can be very effective at relieving symptoms of severe depression. It is often used when other medications haven't worked or when there is a need to respond quickly for medical reasons.
Repetitive transcranial magnetic stimulation (rTMS) is an intense treatment where magnetic pulses are used to stimulate specific brain regions. Patients typically receive several treatments over a few weeks.
This kind of treatment isn’t to be taken lightly, and results vary, with some patients reporting “miraculous” recovery, and others reporting worsened symptoms. Currently, most evidence is anecdotal. More clinical trials are needed to confirm its efficacy.
Other approaches remain under study. These include magnetic seizure therapy and deep brain stimulation.
Psychedelic-Assisted Therapy and Emerging Treatments
Psychedelic-assisted therapy is a highly interesting new area of study, which involves taking drugs that in the past were associated with illicit activity. Today, these studies are performed under controlled and supportive therapeutic environments.
Psychedelic-assisted treatments are still considered experimental for treating depression. They aren’t a proven alternative to currently FDA-approved antidepressants or talk therapy. Experts have yet to determine the parameters that might define safe and effective treatment.
Areas of ongoing research also include rapidly-acting antidepressants, drugs acting on other neurotransmitters than the current drugs do, and targeted drugs based on a person's genetics or biology. Ideally, personalized medicine can allow physicians to determine better options sooner.
How Clinical Trials Expand Depression Treatment
Clinical trials are key to the discovery of new and improved treatments for depression. Without them, treatment would stagnate and millions of people who don’t respond well to existing treatments would have to continue suffering.
With clinical trials for depression, researchers home in on the safety of proposed new medications and treatment methods. With the help of volunteer participants, new treatments can be brought to market.
There are different phases that trials go through. The beginning studies focus on safety and dosing. Following studies focus on the medication's effectiveness in larger groups of people. Once the data is supplied to the FDA, it takes about five years for approval, if granted. At that point, the treatment may be made available to the general public, where it could help millions who suffer from depression.
You can find depression clinical trials at ClinicalTrials.gov. There are several useful filters that you can use to find ones that may be suitable for your goals. In the study descriptions you can find out where the study is being held, some of the general terms of the study and some of the details of the study procedures.
The National Institute of Mental Health's clinical trial participation guide also has information about finding studies and contacting researchers.
Eligibility for depression clinical trials is based on a lot of different factors. When you apply to a study, you’ll be evaluated to see if you fit the criteria for what the study is looking for. If conditionally accepted, you’ll have ample opportunity to learn all the details about the risks, the benefits and the expectations.
The Future of Depression Treatment
Treatment for depression is evolving with humankind’s increasing understanding of brain physiology and mood regulation. It’s early days yet. But, as alternative treatments like neuromodulation and investigational drugs are studied more, additional options will open up for people who suffer from depression.
As time goes on, more studies accumulate data and knowledge that may one day allow doctors to tailor treatment and track patient improvement more accurately. This could lead to better symptom control and/or more options for those who have been unsuccessful in the past.